sinc
emerg
decemb
coronaviru
diseas
spread
countri
declar
pandem
world
health
organ
viru
caus
design
sever
acut
respiratori
syndrom
coronaviru
estim
infect
one
million
individu
result
death
date
commun
transmiss
viru
confirm
across
inhabit
contin
emerg
measur
taken
curb
transmiss
diseas
positivesens
singlestrand
rna
betacoronaviru
share
sequenc
homolog
pathogen
coronavirus
includ
middl
east
respiratori
syndrom
coronaviru
merscov
sever
acut
respiratori
syndrom
coronaviru
viru
thought
emerg
anim
reservoir
name
horsesho
bat
infect
vari
wide
sever
primarili
manifest
pneumonia
median
age
patient
report
fifth
decad
life
male
predomin
less
case
occur
patient
younger
year
age
higher
risk
sever
diseas
elderli
underli
medic
comorbid
thought
transmit
mainli
contact
respiratori
droplet
potenti
airborn
rout
howev
presenc
viru
stool
infect
patient
suggest
fecalor
rout
possibl
mode
transmiss
first
case
detect
wuhan
hubei
provinc
china
earli
decemb
first
cohort
patient
link
local
live
anim
market
suggest
emerg
viru
anim
reservoir
unlik
merscov
sarscov
widespread
intern
transmiss
limit
high
case
fatal
rate
limit
persontoperson
transmiss
instanc
happen
larg
extent
healthcar
research
facil
shown
rel
lower
case
fatal
rate
easi
persontoperson
transmiss
potenti
even
asymptomat
phase
diseas
lead
rapid
global
spread
caus
first
known
coronaviru
pandem
although
avail
inform
transmiss
pathogenesi
clinic
present
manag
limit
novelti
new
pandem
still
import
review
avail
literatur
prepar
ongo
increas
number
infect
patient
next
sever
week
potenti
month
present
narr
review
avail
literatur
regard
involv
liver
digest
system
patient
infect
infect
medlin
databas
search
pubm
use
search
queri
construct
follow
medic
subject
head
mesh
term
sever
acut
respiratori
syndrom
coronaviru
supplementari
concept
supplementari
concept
coronaviru
titleabstract
titleabstract
gastroenterolog
mesh
well
addit
differ
keyword
increas
sensit
specif
search
eg
sign
symptom
digest
mesh
gi
gastro
liver
hepat
digest
diarrhea
naus
vomit
abdomen
bowel
colon
bile
bilia
dyspep
stomach
gastr
esophag
duoden
jejun
ile
transamin
similar
search
perform
googl
scholar
engin
refer
list
paper
websit
lead
gastroenterolog
hepatolog
journal
well
center
diseas
control
prevent
public
review
manual
author
full
text
articl
review
author
extract
relev
inform
construct
narr
review
literatur
review
limit
sourc
avail
english
fiftyf
studi
select
fulltext
review
author
pneumonia
common
seriou
clinic
manifest
fever
fatigu
myalgia
dri
cough
common
featur
common
symptom
includ
anorexia
headach
dyspnea
well
sore
throat
rhinorrhea
gastrointestin
gi
symptom
present
less
commonli
includ
diarrhea
liver
test
abnorm
nausea
abdomin
pain
report
patient
wuhan
hospit
diarrhea
present
case
interestingli
none
patient
sever
diseas
need
intens
care
unit
icu
care
diarrhea
case
diarrhea
happen
patient
less
sever
diseas
studi
studi
case
singapor
similarli
report
diarrhea
patient
need
supplement
oxygen
none
case
requir
oxygen
supplement
howev
second
report
patient
hospit
wuhan
show
higher
preval
diarrhea
patient
diarrhea
higher
preval
diarrhea
among
icu
patient
compar
nonicu
patient
differ
statist
signific
author
report
nausea
case
vomit
abdomin
pain
case
interestingli
icu
patient
significantli
like
abdomin
pain
compar
nonicu
patient
vs
p
report
patient
mention
show
elev
level
aspart
aminotransferas
ast
patient
includ
icu
patient
nonicu
patient
studi
patient
hospit
wuhan
show
although
case
preexist
chronic
liver
diseas
none
need
icu
care
cohort
mean
ast
alanin
aminotransferas
alt
mildli
elev
icu
patient
ul
respect
nonicu
patient
ul
astalt
ratio
metaanalysi
studi
report
preval
aminotransferas
elev
patient
differ
studi
studi
patient
china
report
preval
elev
total
bilirubin
mgdl
elev
aminotransferas
level
total
bilirubin
common
among
patient
experienc
composit
outcom
icu
admiss
mechan
ventil
death
elev
alakalin
phosphatas
seem
common
patient
report
happen
case
neither
studi
report
acut
fulmin
liver
injuri
acut
liver
failur
complic
howev
given
third
icu
case
complic
shock
expect
see
vari
degre
ischem
liver
injuri
patient
one
studi
found
alt
level
iul
associ
inpati
mortal
anoth
studi
shown
elev
ast
bilirubin
level
associ
higher
risk
progress
respiratori
failur
death
although
unclear
avail
evid
whether
elev
liver
enzym
independ
predictor
poor
prognosi
abnorm
similar
indic
endorgan
damag
encount
frequent
patient
sever
diseas
need
icu
care
mechan
ventil
consid
find
seem
diarrhea
common
gi
manifest
nausea
vomit
abdomin
pain
mild
elev
ast
alt
present
tabl
previou
studi
shown
higher
preval
diarrhea
gi
symptom
patient
sarscov
merscov
suggest
differ
tropism
compar
although
might
signific
variabl
definit
use
report
gi
symptom
differ
hospit
latest
avail
evid
paper
focus
digest
system
symptom
case
hubei
china
report
diarrhea
case
vomit
abdomin
pain
respect
show
degre
variabl
gi
present
diseas
interestingli
experi
hospit
new
york
observ
mild
diarrhea
present
much
larger
proport
patient
reach
preval
patient
admit
suggest
possibl
differ
clinic
manifest
north
american
popul
final
least
one
report
bloodi
inflammatori
diarrhea
possibl
caus
viru
associ
coliti
suggest
viru
caus
wider
varieti
lumin
present
current
report
importantli
patient
abovement
studi
present
digest
complaint
mention
without
respiratori
symptom
addit
case
present
combin
respiratori
gi
symptom
interestingli
patient
present
gi
symptom
longer
time
onset
diseas
hospit
admiss
compar
patient
without
digest
symptom
vs
p
gi
symptom
observ
increas
sever
durat
separ
studi
also
suggest
show
male
predomin
gi
symptom
diseas
like
present
femal
patient
find
suggest
small
group
patient
might
present
initi
gi
symptom
case
develop
symptom
later
cours
diseas
might
potenti
explan
rel
high
preval
diarrhea
risk
small
bowel
involv
compar
gi
symptom
sarscov
thought
high
affin
angiotensinconvert
enzym
receptor
potenti
permit
viru
entri
cell
ileal
epitheli
cell
significantli
high
express
cholangiocyt
esophag
epitheli
cell
also
express
receptor
potenti
target
viru
avail
report
elev
gammaglutamyl
transferas
diagnost
biomark
cholangiocyt
injuri
patient
half
case
cohort
china
provid
evid
regard
cholangiocyt
injuri
although
express
hepatocyt
rel
lower
cholangiocyt
worth
note
previou
autopsi
liver
biopsi
studi
sarscov
patient
found
viral
particl
hepat
parenchyma
well
eosinophil
bodi
balloon
suggest
hepatocyt
injuri
note
observ
gi
manifest
includ
elev
liver
enzym
confound
advers
reaction
due
differ
pharmacotherapi
agent
patient
discuss
well
associ
ischemia
hypoxia
sever
case
thu
far
proven
specif
treatment
mainstay
manag
remain
support
care
howev
avail
preclin
evid
show
invitro
efficaci
chloroquin
hydroxychloroquin
infect
potenti
increas
endosomi
ph
interf
glycosyl
cellular
receptor
sarscov
led
clinic
use
drug
result
ongo
clinic
trial
pend
import
note
although
chloroquin
hydroxychloroquin
rare
result
clinic
signific
acut
liver
injuri
except
patient
porphyria
cutanea
tarda
use
caution
patient
hepat
impair
take
concurr
hepatotox
medic
experiment
agent
includ
lopinavirritonavir
remdesivir
favipiravir
tocilizumab
sarilumab
siltuximab
unproven
efficaci
use
lopinavirritonavir
associ
gi
advers
reaction
diarrhea
nausea
vomit
abdomin
pain
increas
serum
aminotransferas
amylas
lipas
level
well
risk
hepat
exacerb
underli
chronic
liver
diseas
exampl
patient
chronic
viral
hepat
exampl
four
five
patient
treat
lopinavirritonavir
abovement
studi
singapor
develop
nausea
vomit
andor
diarrhea
three
develop
abnorm
liver
test
howev
public
trial
fail
show
signific
benefit
lopinavirritonavir
use
declin
treatment
similarli
tocilizumab
similar
medic
sarilumab
associ
increas
aminotransferas
level
well
risk
acut
liver
injuri
failur
full
extent
gi
advers
event
antivir
treatment
remdesivir
favipiravir
yet
clear
howev
exist
report
suggest
nausea
vomit
vari
degre
liver
test
abnorm
potenti
side
effect
reason
obtain
baselin
liver
function
test
use
abovement
pharmacolog
agent
manag
continu
monitor
treatment
regard
immunosuppress
medic
use
patient
inflammatori
bowel
diseas
autoimmun
hepat
current
guidanc
multisocieti
task
forc
recommend
continu
medic
given
risk
diseas
flare
associ
complic
current
outweigh
risk
contract
patient
well
patient
chronic
liver
diseas
cirrhosi
counsel
remain
cautiou
follow
guidelin
atrisk
group
optim
hand
hygien
social
isol
minim
risk
pandem
exampl
report
china
suggest
simpl
intervent
send
messag
patient
cirrhosi
regard
precaut
take
significantli
decreas
risk
contract
diseas
current
guidelin
center
diseas
control
prevent
recommend
nasopharyng
swab
test
addit
oropharyng
swab
option
presenc
verifi
use
reversetranscript
polymeras
chain
reaction
posit
result
confirm
presenc
due
potenti
fals
neg
result
recommend
resampl
repeat
test
case
neg
result
clinic
suspicion
mention
earlier
rna
present
patient
stool
studi
case
china
report
presenc
viral
rna
stool
persist
convalesc
case
case
longer
durat
stool
specimen
stay
posit
viral
rna
compar
viral
rna
throat
swab
median
delay
separ
studi
patient
confirm
fecal
respiratori
sampl
test
report
viral
rna
posit
case
neg
case
fecal
rna
remain
posit
convalesc
longer
period
compar
respiratori
sampl
mean
vs
first
symptom
stay
posit
wk
initi
present
although
stool
sampl
current
use
diagnosi
find
suggest
potenti
role
stool
sampl
use
diagnosi
evalu
risk
transmiss
need
isol
convalesc
well
potenti
risk
fecalor
transmiss
diseas
interestingli
report
patient
posit
fecal
viral
test
sever
neg
pharyng
sputum
polymeras
chain
reaction
test
time
suggest
fecal
test
potenti
play
role
diagnosi
fecal
microbiata
transplant
donor
special
group
potenti
widespread
transmiss
diseas
test
viral
rna
stool
sampl
serious
consid
especi
histori
typic
symptom
past
wk
final
reason
consid
donor
recipi
liver
transplant
special
popul
recommend
univers
test
liver
transplant
mention
given
report
small
minor
patient
initi
present
exclus
gi
symptom
import
gi
consult
remain
vigil
includ
differenti
diagnosi
even
absenc
respiratori
symptom
especi
febril
patient
multisocieti
guidelin
publish
march
aasld
acg
aga
asg
recommend
postpon
nonurg
endoscop
procedur
pandem
exampl
procedur
includ
screen
surveil
endoscop
procedur
asymptomat
patient
colon
cancer
screen
barrett
esophagu
surveil
esophag
ph
test
motil
studi
esophag
anorect
manometri
diagnost
procedur
result
urgent
need
endoscop
ultrasound
exam
pancreat
cyst
intermedi
risk
malign
natur
endoscopist
continu
perform
procedur
urgent
case
food
impact
sever
dysphagia
gi
bleed
cholang
acut
biliari
obstruct
timesensit
endoscop
examin
evalu
malign
endoscop
echoendoscop
stage
multipl
guidelin
publish
differ
gi
endoscop
societi
provid
detail
regard
endoscopi
pandem
patient
screen
presenc
fever
clinic
symptom
compat
accord
institut
protocol
prior
admiss
endoscopi
suit
number
peopl
present
endoscopi
suit
minim
decreas
risk
exposur
transmiss
usag
person
protect
equip
ppe
given
presenc
viral
dna
pharyng
gi
secret
risk
aerosol
minim
effici
intub
need
experienc
anesthesiolog
provid
minim
length
endoscop
procedur
use
addit
standard
ppe
includ
dispos
hairnet
gown
glove
surgic
mask
face
shield
provid
consid
use
respir
equival
provid
care
patient
pandem
author
suggest
use
respir
confirm
high
risk
case
upper
endoscopi
intermedi
risk
patient
note
near
univers
spread
viru
across
commun
qualifi
almost
patient
highrisk
accord
current
guidelin
need
use
respir
endoscop
procedur
final
reason
chang
gastroenterolog
hepatolog
clinic
visit
telehealth
care
use
phone
call
video
visit
accord
avail
institut
protocol
patient
absolut
need
physic
examin
current
pandem
due
viru
caus
extrem
burden
health
care
system
global
number
case
expect
continu
increas
least
immedi
futur
familiar
health
care
provid
viru
clinic
manifest
significantli
help
effici
time
manag
patient
review
avail
literatur
focu
gi
manifest
present
avail
report
suggest
gi
involv
less
common
compar
previou
coronaviru
outbreak
name
sarscov
merscov
nonetheless
signific
proport
patient
present
gi
symptom
sign
addit
cardin
manifest
lower
respiratori
tract
involv
pneumonia
case
gi
symptom
may
preced
respiratori
symptom
common
lumin
manifest
diseas
diarrhea
report
case
avail
literatur
limit
regard
sever
diarrhea
high
express
ileum
suggest
potenti
target
viru
gi
tract
addit
mild
moder
elev
aminotransferas
report
case
although
acut
liver
failur
report
direct
consequ
sever
extent
abnorm
liver
test
seem
associ
diseas
sever
wors
outcom
import
note
medic
use
manag
chloroquin
lopinavirritonavir
associ
vari
degre
liver
test
abnorm
gi
advers
reaction
import
obtain
baselin
evalu
patient
liver
function
initi
treatment
continu
monitor
liver
function
test
treatment
also
import
check
patient
presenc
chronic
viral
hepat
hbv
hcv
well
risk
factor
chronic
liver
diseas
especi
alcohol
use
start
treatment
agent
addit
direct
effect
similar
patient
sever
ill
patient
remain
risk
complic
commonli
manag
gastroenterolog
hepatolog
consult
c
difficil
infect
context
frequent
antibiot
use
ischem
liver
injuri
cholestasi
critic
ill
detail
delay
endoscop
procedur
nonurg
case
strict
adher
hand
hygien
contact
precaut
correct
use
ppe
help
minim
risk
exposur
transmiss
pandem
conserv
healthcar
resourc
